Bank Of New York Mellon Corp Takeda Pharmaceutical CO LTD Transaction History

Bank Of New York Mellon Corp

$528 Trillion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$12.42 - $15.62 $1.75 Million - $2.2 Million	140,822 New	140,822 $2.2 Million
Q3 2022 Nov 14, 2022	BUY	$12.8 - $28.65 $361,894 - $810,021	28,273 Added 39.57%	99,718 $1.29 Million
Q2 2022 Aug 15, 2022	BUY	$13.12 - $15.03 $100,289 - $114,889	7,644 Added 11.98%	71,445 $1 Million
Q1 2022 May 11, 2022	BUY	$13.54 - $15.35 $178,795 - $202,696	13,205 Added 26.1%	63,801 $914,000
Q4 2021 Feb 11, 2022	SELL	$13.17 - $16.4 $139,206 - $173,347	-10,570 Reduced 17.28%	50,596 $689,000
Q3 2021 Nov 12, 2021	SELL	$16.3 - $17.26 $82,836 - $87,715	-5,082 Reduced 7.67%	61,166 $1 Million
Q2 2021 Aug 11, 2021	BUY	$16.55 - $18.64 $17,493 - $19,702	1,057 Added 1.62%	66,248 $1.11 Million
Q1 2021 May 13, 2021	SELL	$16.71 - $19.9 $283,769 - $337,941	-16,982 Reduced 20.67%	65,191 $1.19 Million
Q4 2020 Feb 09, 2021	SELL	$15.39 - $18.97 $56,435 - $69,562	-3,667 Reduced 4.27%	82,173 $1.5 Million
Q3 2020 Nov 12, 2020	SELL	$17.1 - $19.19 $411,152 - $461,404	-24,044 Reduced 21.88%	85,840 $1.53 Million
Q2 2020 Aug 12, 2020	SELL	$14.59 - $19.5 $310,927 - $415,564	-21,311 Reduced 16.24%	109,884 $1.97 Million
Q1 2020 May 06, 2020	BUY	$13.02 - $20.31 $279,851 - $436,543	21,494 Added 19.59%	131,195 $1.99 Million
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $248,000 - $306,034	-14,692 Reduced 11.81%	109,701 $2.16 Million
Q3 2019 Nov 07, 2019	SELL	$16.15 - $17.99 $707,289 - $787,872	-43,795 Reduced 26.04%	124,393 $2.14 Million
Q2 2019 Aug 12, 2019	SELL	$16.58 - $20.49 $1.7 Million - $2.1 Million	-102,636 Reduced 37.9%	168,188 $2.98 Million
Q1 2019 May 14, 2019	BUY	$16.7 - $21.52 $4.11 Million - $5.29 Million	245,980 Added 990.1%	270,824 $5.52 Million
Q4 2018 Feb 11, 2019	BUY	$15.64 - $21.1 $388,560 - $524,208	24,844 New	24,844 $418,000

Others Institutions Holding TAK

# of Institutions

320

Shares Held

70.4M

Call Options Held

939K

Put Options Held

233K

Capital Research Global Investors Los Angeles, CA

13.1M
Shares

$182 Million
0.04% of portfolio
Mondrian Investment Partners LTD London, X0

7.74M
Shares

$107 Million
1.74% of portfolio
Morgan Stanley New York, NY

4.99M
Shares

$69.1 Million
0.01% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.35M
Shares

$60.2 Million
0.03% of portfolio
Goldman Sachs Group Inc New York, NY

3.72M
Shares

$51.5 Million
0.01% of portfolio

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account